...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Eating Disorders >Treatment of children and adolescents with avoidant/restrictive food intake disorder: a case series examining the feasibility of family therapy and adjunctive treatments
【24h】

Treatment of children and adolescents with avoidant/restrictive food intake disorder: a case series examining the feasibility of family therapy and adjunctive treatments

机译：避免/限制食物摄入障碍的儿童和青少年的治疗：一个病例系列，探讨家庭治疗和辅助治疗的可行性

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background To date, little research has examined the effectiveness of either modified Family-Based Therapy or psychopharmacological treatments for patients diagnosed with avoidant/restrictive food intake disorder (ARFID), and there is little evidence to guide clinicians treating children and adolescents with ARFID.?This case series describes the clinical presentations, treatments and outcomes of?six patient diagnosed with ARFID who?were?treated sequentially?by a child psychiatrist and adolescent medicine physician in a hospital-based eating disorder program. Case Presentations Five out of six cases were female and median age of patients at assessment was 12.9 ( SD =?1.13) years. On average, patients’ percentage of treatment goal weight was 80.5% at initial assessment ( SD =?8.56) and 81.9% ( SD =?7.08) when family therapy began. Cases 1, 2 and 3 were admitted to a specialized inpatient unit at assessment due to medical instability (2) or failed outpatient treatment (1), and all six cases presented with severe co-morbid anxiety. All patients were treated using a combination of medical monitoring, family therapy, medication (including olanzapine, fluoxetine and in two cases cyproheptadine), and cognitive behavioural therapy. At treatment termination, all six patients had achieved their goal weight. Conclusion These cases illustrate the complex ways in which young patients with ARFID can present, the illness’ effect on development and mental health, and the positive outcomes associated with weight gain and concurrent treatment for co-morbid anxiety disorders.
机译：背景技术迄今为止，很少有研究检查改良的基于家庭的疗法或心理药物治疗对诊断为避免/限制性食物摄入障碍（ARFID）的患者的有效性，并且几乎没有证据指导临床医生使用ARFID治疗儿童和青少年。本病例系列描述了在医院饮食失调项目中由儿童精神病医生和青少年医学医师相继治疗的六名经ARFID诊断的患者的临床表现，治疗方法和结果。病例介绍六分之五的病例是女性，接受评估的患者中位年龄为12.9岁（SD =？1.13）。平均而言，初次评估时患者的治疗目标体重百分比为80.5％（SD =？8.56），开始家庭治疗时为81.9％（SD =？7.08）。由于医疗不稳定（2）或门诊治疗失败（1），第1、2和3例病例进入评估时进入专门的住院病房，所有6例患者均患有严重的合并症焦虑症。所有患者均接受了医学监测，家庭治疗，药物治疗（包括奥氮平，氟西汀和两种情况下的赛庚啶）和认知行为治疗的组合。在治疗终止时，所有六名患者均达到了目标体重。结论这些案例说明了年轻的ARFID患者可以表现的复杂方式，疾病对发育和心理健康的影响以及与体重增加和合并症共同治疗相关的积极结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号